logo-loader

Benitec Biopharma queried by ASX

Last updated: 18:00 11 Nov 2014 AEDT, First published: 17:00 11 Nov 2014 AEDT

au_medical_350_54619757e597d

Benitec Biopharma (ASX:BLT) has received a price / volume query from the ASX after its shares surged from a close of $0.72 on Monday, 10 November 2014 to an intraday high of $1.01 today.

Trading volume was over 1.5 million shares.

Recently, the company signed a licensing agreement with U.S. based biotech company Circuit Therapeutics to use Benitec’s gene-­‐silencing technology called ddRNAi in the area of intractable pain.

 


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

13 hours, 25 minutes ago